NIO Inc. (NIO) Announces Proposed 75M ADS Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
NIO Inc. (NIO) Prices 88.5M ADS Offering at $17?ADS
August 31, 2020 5:51 AM EDTNIO Inc. (NYSE: NIO), a pioneer in Chinas premium smart electric vehicle market, today announced the pricing of the offering of 88,500,000 American depositary shares (the ADSs), each representing one Class A ordinary share of the Company (the ADS Offering), at a price of US$17.00... More
China's Xpeng surges 67% on U.S. debut, raises $1.5 billion in IPO
August 26, 2020 9:12 PM EDTBy Yilei Sun and Scott Murdoch
(Reuters) - Shares of Chinese electric vehicle (EV) maker Xpeng Inc (NYSE: XPEV) jumped as much as 67% after its U.S. market debut on Thursday, as capital markets continue to reward new listings in what has been one of the best years for IPOs since the dotcom boom.
Shares of Xpeng, which counts Chinese e-commerce titan Alibaba (NYSE: BABA) and Xiaomi Corp among its backers, opened at $23.10 per American Depositary Share (ADS), up from the raised offer price of... More
Pre-Open Movers 08/26: (FLDM) (DKS) (CRM) Higher; (PSTG) (LRN) (JWN) Lower (more...)
August 26, 2020 9:23 AM EDTToday's Pre-Open Movers
Tyme Technologies, Inc. (NASDAQ: TYME) 32.4% HIGHER; announced a potential new approach to treating COVID-19 using a metabolic agent, TYME-19. TYME-19 is a synthetic bile acid, a family of metabolic agents that the Company also uses in its anticancer product, TYME-18. Because of its expertise in metabolic therapies, the Company was able to quickly identify TYME-19 as a potent, well characterized antiviral bile acid and has performed preclinical experiments establishing effectiveness against... More
Citi Reiterates Buy Rating on NIO (NIO) After Hosting Conference Call to Discuss Biz Model Changes
August 26, 2020 6:18 AM EDTCiti analyst Jeff Chung reiterated a Buy rating and $16.00 price target on NIO (NYSE: NIO) after the hosting an investor update call with Nios management on August 26th to get further insights into its newly-launched Battery as a Service (BaaS) model. Key points include:
The company offers two options to consumers when purchasing a vehicle: 1) consumers can opt to buy vehicles with batteries or 2)... More
Morgan Stanley Upgrades NIO (NIO) to Overweight; Bullish on Hefei Deal
August 26, 2020 4:25 AM EDT(Updated - August 26, 2020 4:28 AM EDT)
(updating comment)
Morgan Stanley analyst Tim Hsiao upgraded NIO (NYSE: NIO) from Equalweight to Overweight with a price target of $20.50 (from $12.00).
THe analyst comments "The recent Hefei deal not only removes funding risk but also advances... More

